Alzheimer's disease: the tacrine legacy

Trends Pharmacol Sci. 1999 Apr;20(4):127-9. doi: 10.1016/s0165-6147(99)01344-9.

Author

J S Kelly¹

Affiliation

¹ Fujisawa Institute for Neuroscience, Department of Neuroscience, The University of Edinburgh, UK.

PMID: 10348719
DOI: 10.1016/s0165-6147(99)01344-9

No abstract available

MeSH terms

Alzheimer Disease / drug therapy*
Cholinesterase Inhibitors / therapeutic use*
Humans
Muscarinic Agonists / therapeutic use
Tacrine / therapeutic use*
Xanthines / therapeutic use

Substances

Cholinesterase Inhibitors
Muscarinic Agonists
Xanthines
Tacrine
propentofylline